Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells

Journal of Theoretical Biology

Volumn 243, Issue 2, 2006, Pages 191-204

  Heffernan, Jane M ^a   Wahl, Lindi M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Activation; CD4 T cell count; CD8 T cell count; Effector cell; HIV; Mathematical model; Monte Carlo simulation; Proliferation; Stochastic model; Variability; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DISEASE TREATMENT; DRUG PRESCRIBING; HUMAN IMMUNODEFICIENCY VIRUS; MONTE CARLO ANALYSIS; STOCHASTICITY;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CORRELATION ANALYSIS; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MONTE CARLO METHOD; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMULATION; STATISTICAL SIGNIFICANCE; STOCHASTIC MODEL; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MODELS, IMMUNOLOGICAL; MONTE CARLO METHOD; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33749600742     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2006.05.032     Document Type: Article

References (58)

1. Bartlett J.A., DeMasi R., Dawson D., and Hill A. Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment. J. Inf. Dis. 178 (1998) 1803-1805
2. Brambilla, D., Reichelderfer, P.S., Bremer, J.W., Shapiro, D.E., Hershow, R.C., Katzenstein, D.A., Hammer, S.M., Jackson, B., Collier, A.C., Sperling, R.S., Fowler, M.G., Coombs, R.W. For participating adult and pediatric AIDS clinical trials groups, the women infant transmission study clinics and laboratories participating in the virology quality assurance program, 1999. The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. AIDS 13(16), 2269-2279.
3. Chao D.L., Davenport M.P., Forrest S., and Perelson A.S. A stochastic model of catatonic T cell responses. J. Theor. Biol. 228 (2004) 227-240
4. Coles R.M., Mueller S.N., Heath W.R., Carbone F.R., and Brooks A.G. Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1. J. Immunol. 168 (2002) 834-838
5. Coombs R.W., Speck C.E., Hughes J.P., Lee W., Sampoleo R., Ross S.O., Dragaavon J., Peterson G., Hooton T.M., Collier A.C., Corey L., Koutsky L., and Krieger J.N. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J. Inf. Dis. 177 (1998) 320-330
6. Culshaw R.V., and Ruan S. A delay-differential equation model of HIV infection of CD4+ T-cells. Math. Biosci. 165 (2000) 27-39
7. da Silva, J., Hughes, A., 2002. Monte Carlo simulation of HIV-1 evolutions in response to selection by antibodies. IPDPS 2002.
8. De Boer R.J., and Perelson A.S. Towards a general function describing t-cell proliferation 175 4 (1995) 567-576
9. Deeks S.G., Coleman R.L., White R., Pachl C., Schambelan M., Chernoff D.N., and Feinberg M.B. Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days. J. Inf. Dis. 176 (1997) 514-517
10. Gett A.V., and Hodgkin P.D. A cellular calculus for signal integration by T cells. Natl Immunol. 1 (2000) 239-244
11. Haase A.T., Henry K., Zupancic M., Sedgewick G., Faust R.A., Melroe H., Cavert W., Gebhard K., Staskus K., Zhang Z.-Q., Dailey P.J., Balfour Jr. H.H., Erice A., and Perelson A.S. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274 (1996) 985-989
12. Heffernan J.M., and Wahl L.M. Monte Carlo estimates of natural variability in HIV infection. J. Theor. Biol. 236 (2005) 137-153
13. Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373 6510 (1995) 123-126
14. Hughes M.D., Stein D.S., Gundacker H.M., Valentine F.T., Phair J.P., and Volberding P.A. Within-subject variation in CD4 lymphocyte count in asymptotic human immunodeficiency virus infection: implications for patient monitoring. J. Inf. Dis. 169 (1994) 28-36
15. Hughes M.D., Johnson V.A., Hirsch M.S., Bremer J.W., Elbeik T., Erice A., Kuritzkes D.R., Scott W.A., Spector S.A., Basgoz N., Fischl M.A., and DAquila R.T. Monitoring plasma HIV-1 RNA levels in addition to CD4 lymphocyte count improves assessment of antiretroviral therapeutic response. Ann. Int. Med. 126 2 (1997) 929-938
16. Iezii G., Karjalainen K., and Lanzavecchia A. The duration of antigenic stimulation determines the fate of naive and effector cells. Immunity 8 (1998) 89-95
17. Janeway C., and Travers P. Immunobiology: The Immune System in Health and Disease (2005), Garland, New York
18. Josuttis N.M. The C++ Standard Library (1999), Addison-Wesley, Boston
19. Kaech S.M., and Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a development program in naive cells. Nat. Immunol. 2 5 (2001) 415-422
20. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2 (2002) 251-262
21. Kamina A., Makuch R.W., and Zhao H. A stochastic modeling of early HIV-1 population dynamics. Math. Biosci. 170 (2001) 187-198
22. Kirschner, D., 1996. Using mathematics to understand HIV immune dynamics. AMS Notices February 1996.
23. Kirschner D., Webb G.F., and Cloyd M. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4+ lymphocytes. JAIDS 24 4 (2000) 352-362
24. Klenerman P., Phillips R.E., Rinaldo C.R., Wahl L.M., Ogg G., May R.M., McMichael A.J., and Nowak M.A. Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc. Natl Acad. Sci. USA 93 (1996) 15323-15328
25. Kousignian, I., Autran, B., Chouquet, C., Calvez, V., Gomard, E., Katlama, C., Riviere, Y., the IMMUNOCO Study group, Costagliola, D., 2003. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients. Stat. Med. 22, 1675-1690.
26. + cell counts, and HIV-1 production by cells. Science 271 5249 (1996) 670-671
27. Lloyd A.L. Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics. Theor. Popul. Biol. 60 (2001) 59-71
28. Margolick J.B., and Donnenberg A.D. T-cell homeostasis in HIV-1 infection. Semin. Immunol. 9 (1997) 381-388
29. Mathworks, 2005. MATLAB fmincon www.mathworks.com.
30. McLean A.R. Modelling T cell memory. J. Theor. Biol. 170 (1994) 63-74
31. Mohri H., Perelson A.S., Tung K., Ribeiro R.M., Ramratnam B., Markowitz M., Kost R., Hurley A., Weinberger L., Cesar D., Hellerstein M.K., and Ho D.D. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194 9 (2001) 1277-1287
32. Nelson P.W., and Perelson A.S. Mathematical analysis of delay differential equation model of HIV-1 infection. Math. Biosci. 179 (2002) 73-94
33. Nelson P.W., Gilchrist M.A., Coombs D., Hyman J.M., and Perelson A.S. An age-structured model of HIV infection that allows for variations in the production rate of viral particles and the death rate of productively infected cells. Math. Biosci. 1 (2004) 267-288
34. Nowak M.A., and May R.M. Virus Dynamics (2000), Oxford University Press, Oxford
35. Nowak M.A., Lloyd A.L., Vasquez G.M., Wiltrout T.A., Wahl L.M., Bischofberger N., Williams J., Kinter A., Fauci A.S., Hirsch W.M., and Lifson J.D. Viral dynamics of primary viremia and antiretroviral therapy in Simian immunodeficiency virus infection. J. Virol. 71 (1997) 7518-7525
36. Oehen S., and Brduscha-Riem K. Differentiation of naive CTL tp effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161 (1998) 5338-5346
37. Opferman J.T., Ober B.T., and Ashton-Rikardt P.G. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283 (1999) 1745-1748
38. Paxton, W.B., Coombs., R.W., McElrath, M.J., Keefer, M.C., Hughes, J., Sinangil, F., Chernoff, D., Demeter, L., Williams, B., Corey, L., for the National Institute of Allergy and Infectious Diseases AIDS Vaccines Evaluation Group, 1997. Longitudinal analysis of quantitative virologic measures in human immunodeficiency virus-Infected subjects with ≥ 400 CD4 lymphocytes: implications for applying measurements to individual patients. J. Inf. Dis. 175, 247-254.
39. Perelson A.S. Modelling viral and immune system dynamics. Nature 2 (2002) 28-36
40. Perelson A.S., and Nelson P.W. Mathematical analysis of HIV-1 dynamics in vivo. SIAM Rev. 41 1 (1999) 3-44
41. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 271 (1996) 1582-1585
42. Perelson A.S., Essunger P., Cao Y., Vesanen M., Hurley A., Saksela K., Markowitz M., and Ho D.D. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387 (1997) 188-191
43. Raboud J.M., Montaner J.S.G., Conway B., Haley L., Sherlock C., O'Shaughnessy M.V., and Schechter M.T. Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J. Inf. Dis. 174 (1996) 191-194
44. + T cells depleted. Proc. Natl Acad. Sci. 99 24 (2002) 15572-15577
45. Ruskin H.J., Pandey R.B., and Liu Y. Viral load and stochastic mutation in a Monte Carlo simulation of HIV. Physica A 311 (2002) 213-220
46. Smith R., and Wahl L.M. Distinct effect of protease and reverse transcriptase inhibition in an immunological model of HIV-1 infections with impulsive drug effects. Bull. Math. Biol. 66 (2004) 1259-1283
47. Smith R., and Wahl L.M. Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects. Bull. Math. Biol. 67 4 (2005) 783-813
48. Stafford M.A., Cao Y., Ho D.D., Corey L., and Perelson A.S. Modeling plasma virus concentration during primary HIV infection. J. Theor. Biol. 203 (2000) 285-301
49. Tan W.-Y., and Wu H. Stochastic modeling of the dynamics of CD4+ T-cell infection by HIV and some Monte Carlo studies. Math. Biosci. 147 (1998) 173-205
50. Tuckwell H.C., and Le Corfec E. A stochastic model for early HIV-1 population dynamics. J. Theor. Biol. 195 (1998) 451-463
51. van Stipdonk M.J., Lemmens E.E., and Schoenberger S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2 (2001) 423-429
52. Veiga-Fernandes H., Walter U., Bourgeois C., McLean A., and Rocha B. Response of naive and memory Cd8+ T cells to antigen stimulation in vivo. Nat. Immunol. 1 (2000) 47-53
53. Wei L.M., Ghosh S.K., Taylor M.E., Hohnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., Saag M.S., and Shaw G.M. Viral dynamics in HIV-1 infection. Nature 373 (1995) 117-122
54. Weiss R.A. How does HIV cause AIDS?. Science 260 (1993) 1273-1278
55. Wodarz D., Klenerman P., and Nowak M. Dynamics of catatonic T-lymphocyte exhaustion. Proc. R. Soc. London B 265 (1998) 191-203
56. Wodarz D., Lloyd A.L., Jansen V.A.A., and Nowak M.A. Dynamics of macrophage and T cell infection by HIV. J. Theor. Biol. 196 (1999) 101-113
57. Wu H., and Ding A.A. Population HIV-1 dynamics in vivo: applicable models and inferential tool for virological data from AIDS clinical trials. Biometrics 55 (1999) 410-418
58. Yamashita T.E., Modjarrad K., and Munoz A. Variability of HIV-1 RNA before AIDS and highly active antiretroviral therapy. AIDS 17 8 (2003) 1264-1267